Gene: CHST11
Official Full Name: carbohydrate sulfotransferase 11provided by HGNC
Gene Summary: The protein encoded by this gene belongs to the sulfotransferase 2 family. It is localized to the golgi membrane, and catalyzes the transfer of sulfate to position 4 of the N-acetylgalactosamine (GalNAc) residue of chondroitin. Chondroitin sulfate constitutes the predominant proteoglycan present in cartilage, and is distributed on the surfaces of many cells and extracellular matrices. A chromosomal translocation involving this gene and IgH, t(12;14)(q23;q32), has been reported in a patient with B-cell chronic lymphocytic leukemia. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23402 | CHST11 Knockout cell line (HeLa) | Human | CHST11 | 1:3~1:6 | Negative | Online Inquiry |
KO23403 | CHST11 Knockout cell line (HCT 116) | Human | CHST11 | 1:2~1:4 | Negative | Online Inquiry |
KO23404 | CHST11 Knockout cell line (HEK293) | Human | CHST11 | 1:3~1:6 | Negative | Online Inquiry |
KO23405 | CHST11 Knockout cell line (A549) | Human | CHST11 | 1:3~1:4 | Negative | Online Inquiry |
CHST11 Gene Knockout Cell Lines are engineered stem cell lines specifically designed to functionally deactivate the CHST11 gene, which encodes for a key enzyme involved in the sulfation of glycosaminoglycans. This targeted gene editing leverages CRISPR/Cas9 technology to bring about precise modifications to the genomic sequence, resulting in the absence of the CHST11 protein. The disruption of CHST11 serves as a powerful tool for researchers studying the biological implications of sulfation patterns on extracellular matrices and cell signaling pathways.
The key function of CHST11 involves modulating the sulfation of heparan sulfate, which plays a pivotal role in cellular interactions, growth factor signaling, and tissue integrity. By studying the knockout variants, researchers can elucidate the biochemical pathways influenced by sulfated glycosaminoglycans and advance our understanding of related diseases and developmental processes. This innovative tool is invaluable for both academic research and clinical applications that explore gene function, cell behavior, and therapeutic interventions.
One significant advantage of CHST11 Gene Knockout Cell Lines is their ability to provide a reliable and reproducible model for in vivo and in vitro studies, which is crucial for ensuring experimental validity. Unlike traditional knockout methods, our cell lines exhibit stable genetic alterations that facilitate long-term studies and high-throughput screening, making them a preferred tool in various research settings.
Additionally, the specificity of gene editing minimizes off-target effects, significantly increasing reliability when evaluating the role of CHST11 in diverse biological contexts. Researchers and clinicians can thus confirm hypotheses with higher accuracy using our state-of-the-art knockout models.
Our company prides itself on its cutting-edge expertise in gene editing technologies and its commitment to advancing the life sciences through innovative biological products. With a focus on quality and reproducibility, our CHST11 Gene Knockout Cell Lines represent a unique asset for those looking to gain deeper insights into gene function and its implications across health and disease.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.